Treatment of sudden sensorineural hearing loss I. A systematic review

Archives of Otolaryngology - Head and Neck Surgery

Volumn 133, Issue 6, 2007, Pages 573-581

  Conlin, Anne Elizabeth ^a   Parnes, Lorne S ^b  

^a UNIVERSITY OF OTTAWA   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ALPHA TOCOPHEROL; ALTEPLASE; ANTIVIRUS AGENT; BATROXOBIN; BETAMETHASONE; CARBOGEN; DEXAMETHASONE; DEXTRAN; FIBRINOGEN; FLUDIAZEPAM; GINKGO BILOBA EXTRACT; HYDROCORTISONE; MAGNESIUM SULFATE; METHYLPREDNISOLONE; NICAMETATE; NIFEDIPINE; PENTOXIFYLLINE; PLACEBO; PREDNISOLONE; PREDNISONE; PROCAINE; PROSTAGLANDIN E1; STEROID; VALACICLOVIR; VITAMIN B GROUP;

ADD ON THERAPY; ARTICLE; AUDIOMETRY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FATIGUE; HEADACHE; HEARING LOSS; HEMODILUTION; HUMAN; HYPERBARIC OXYGEN; NAUSEA; PERCEPTION DEAFNESS; RANDOMIZED CONTROLLED TRIAL; SALVAGE THERAPY; SYSTEMATIC REVIEW; TINNITUS; VERTIGO;

ANTIVIRAL AGENTS; AUDIOMETRY; HEARING LOSS, SENSORINEURAL; HEARING LOSS, SUDDEN; HUMANS; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS; REPRODUCIBILITY OF RESULTS; STEROIDS; TREATMENT OUTCOME;

EID: 34250811386     PISSN: 08864470     EISSN: 08864470     Source Type: Journal    
DOI: 10.1001/archotol.133.6.573     Document Type: Article

References (36)

1. National Institute of Health. Sudden Deafness. Bethesda, Md: National Institutes of Health; 2000. NIH publication 00-4757.
2. Byl FM. Sudden hearing loss: eight years' experience and suggested prognostic table. Laryngoscope. 1984;94:647-661.
3. Chandrasekhar SS. Updates on methods to treat sudden hearing loss. Oper Tech Otolaryngol Head Neck Surg. 2003;14:288-292.
4. Reisser CH, Weidauer H. Gingko biloba extract EGb 761 or pentoxifylline for the treatment of sudden deafness: a randomized, reference-controlled, double blind study. Acta Otolaryngol. 2001;121:579-584.
5. Ogawa K, Takei S, Inoue Y, Kanzaki J. Effect of prostaglandin E1 on idiopathic sudden sensorineural hearing loss: a double-blind clinical study. Otol Neurotol. 2002;23:665-668.
6. Mattox DE, Simmons FB. Natural history of sudden sensorineural hearing loss. Ann Otol Rhinol Laryngol. 1977;86:463-480.
7. Jones N, Ludman H. Acquired sensorineural hearing loss. In: Ludman H, Wright T, eds. Diseases of the Ear. 6th ed. London, England: Arnold Publishers; 1998:495-497.
8. Haberkamp TJ, Tanyeri HM. Management of idiopathic sudden sensorineural hearing loss. Am J Otol. 1999;20:587-595.
9. Koç A, Sanisoglu O. Sudden sensorineural hearing loss: literature review on recent studies. J Otolaryngol. 2003;32:308-313.
10. Rauch SD. Invited comment to: Haberkamp TJ, Tanyeri HM. Management of idiopathic sudden sensorineural hearing loss. Am J Otol. 1999;20:587-595.
11. Conlin AE, Parnes LS. Treatment of sudden sensorineural hearing loss, II: a meta-analysis. Arch Otolaryngol Head Neck Surg. 2007;133:582-586.
12. Berlin JA; University of Pennsylvania Meta-analysis Blinding Study Group. Does blinding of readers affect the results of meta-analyses? Lancet. 1997;350:185-186.
13. Guyatt GH, Sackett DL, Cook DJ; Evidence-Based Medicine Working Group. Users' guides to the medical literature, II: how to use an article about therapy or prevention, A: are the results of the study valid? JAMA. 1993;270:2598-2601.
14. Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA. 1995;273:408-412.
15. Wilson WR, Byl FM, Laird N. The efficacy of steroids in the treatment of idiopathic sudden hearing loss. Arch Otolaryngol. 1980;106:772-776.
16. Cinamon U, Bendet E, Kronenberg J. Steroids, carbogen or placebo for sudden hearing loss: a prospective double-blind study. Eur Arch Otorhinolaryngol. 2001;258:477-480.
17. Tucci DL, Farmer JC, Kitch RD, Witsell DL. Treatment of sudden sensorineural hearing loss with systemic steroids and valacyclovir. Otol Neurotol. 2002;23:301-308.
18. Stokroos RJ, Albers FWJ, Tenvergert EM. Antiviral treatment of idiopathic sudden sensorineural hearing loss: a prospective, randomized, double-blind clinical trial. Acta Otolaryngol. 1998;118:488-495.
19. Westerlaken BO, Stokroos RJ, Dhooge IJ, Wit HP, Albers FW. Treatment of idiopathic sudden sensorineural hearing loss with antiviral therapy: a prospective, randomized, double-blind clinical trial. Ann Otol Rhinol Laryngol. 2003;112:993-1000.
20. Uri N, Doweck I, Cohen-Kerem R, Greenberg E. Acyclovir in the treatment of idiopathic sudden sensorineural hearing loss. Otolaryngol Head Neck Surg. 2003;128:544-549.
21. Kubo T, Matsunaga T, Asai H, et al. Efficacy of defibrinogenation and steroid therapies on sudden deafness. Arch Otolaryngol Head Neck Surg. 1988;114:649-652.
22. Ho HG, Lin HC, Shu MT, Yang CC, Tsai HT. Effectiveness of intratympanic dexamethasone injection in sudden deafness patients as salvage treatment. Laryngoscope. 2004;114:1184-1189.
23. Probst R, Tschopp K, Ludin E, Kellerhals B, Podvinec M, Pfaltz CR. A randomized, double-blind, placebo-controlled study of dextran/pentoxifylline medication in acute acoustic trauma and sudden hearing loss. Acta Otolaryngol. 1992;112:435-443.
24. Kronenberg J, Almagor M, Bendet E, Kushnir D. Vasoactive therapy versus placebo in the treatment of sudden hearing loss: a double-blind clinical study. Laryngoscope. 1992;102:65-68.
25. Burschka MA, Hassan HAH, Reineke T, van Bebber L, Caird DM, Mosges R. Effect of treatment with Ginkgo biloba extract EGb 761 (oral) on unilateral idiopathic sudden hearing loss in a prospective randomized double-blind study of 106 outpatients. Eur Arch Otorhinolaryngol. 2001;258:213-219.
26. Gordin A, Goldenberg D, Golz A, Netzer A, Joachims HZ. Magnesium: a new therapy for idiopathic sudden sensorineural hearing loss. Otol Neurotol. 2002;23:447-451.
27. Nageris BI, Ulanovski D, Attias J, Tikva P. Magnesium treatment for sudden hearing loss. Ann Otol Rhinol Laryngol. 2004;113:672-675.
28. Suckfüll M; Hearing Loss Study Group. Finbrinogen and LDL apheresis in treatment of sudden hearing loss: a randomized multicentre trial. Lancet. 2002;360:1811-1817.
29. Mann W, Beck C, Beck C. Calcium antagonists in the treatment of sudden deafness. Arch Otorhinolaryngol. 1986;243:170-173.
30. Joachims HZ, Segal J, Golz A, Netzer A, Goldenberg D. Antioxidants in treatment of idiopathic sudden hearing loss. Otol Neurotol. 2003;24:572-575.
31. Mora R, Barbieri M, Mora F, Mora M, Yoo TJ. Intravenous infusion of recombinant tissue plasminogen activator for the treatment of patients with sudden and/or chronic hearing loss. Ann Otol Rhinol Laryngol. 2003;112:665-670.
32. Topuz E, Yigit O, Cinar U, Seven H. Should hyperbaric oxygen be added to treatment in idiopathic sudden sensorineural hearing loss? Eur Arch Otorhinolaryngol. 2004;261:393-396.
33. Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA. 1995;273:408-412.
34. Chalmers TC, Matta RJ, Smith H Jr, Kunzler AM. Evidence favoring the use of anticoagulants in the hospital phase of acute myocardial infarction. N Engl J Med. 1977;297:1091-1096.
35. Kato A, Yonemura K, Matsushima H, Ikegaya N, Hishida A. Complications of oliguric acute renal failure in patients treated with low-molecular weight dextran. Ren Fail. 2001;23:679-684.
36. Kuo ST, Shu WC, Young YH. Dextran-induced pulmonary edema in patients with sudden deafness. Otol Neurotol. 2002;23:661-664.